Abstract
As the human race is still threatened by prospective avian flu endemics, new motivations and systematic approaches should be placed high on agenda in order to alleviate the potential losses of both human life and local economics. A balance and comprehensive measures between economy and the ecosystem of the endemic regions must also be considered. One of the top priorities in these explorations should be effective therapy for infected patients, including better uses and applications of vaccines and antiviral agents. In order to be better prepared for prospective avian flu epidemics, experimental and theoretical inquiry of therapeutic and technical feasibilities against avian viruses in humans deserve to be priority concerned, and extensive experimental and clinical exploitations of fatal pathogenesis of virus infection in human cells at genetic and cytological levels, are urgently needed. In this review, we address and discuss these important questions and review some important solutions for avian flu in future, including antiviral agents, virus vaccinations, Chinese medicine and genetic treatment of the disease.
Keywords: Avian flu, influenza virus, viral pathogenesis, viral treatment, antiviral agents, viral vaccine, human genome, viral genetic pathogenesis, traditional Chinese medicine, medicinal chemistry, neuraminidase inhibitors
Anti-Infective Agents
Title:Avian Flu; Pathogenesis and Therapy
Volume: 10 Issue: 2
Author(s): Da-Yong Lu, Ting-Ren Lu and Hong-Ying Wu
Affiliation:
Keywords: Avian flu, influenza virus, viral pathogenesis, viral treatment, antiviral agents, viral vaccine, human genome, viral genetic pathogenesis, traditional Chinese medicine, medicinal chemistry, neuraminidase inhibitors
Abstract: As the human race is still threatened by prospective avian flu endemics, new motivations and systematic approaches should be placed high on agenda in order to alleviate the potential losses of both human life and local economics. A balance and comprehensive measures between economy and the ecosystem of the endemic regions must also be considered. One of the top priorities in these explorations should be effective therapy for infected patients, including better uses and applications of vaccines and antiviral agents. In order to be better prepared for prospective avian flu epidemics, experimental and theoretical inquiry of therapeutic and technical feasibilities against avian viruses in humans deserve to be priority concerned, and extensive experimental and clinical exploitations of fatal pathogenesis of virus infection in human cells at genetic and cytological levels, are urgently needed. In this review, we address and discuss these important questions and review some important solutions for avian flu in future, including antiviral agents, virus vaccinations, Chinese medicine and genetic treatment of the disease.
Export Options
About this article
Cite this article as:
Lu Da-Yong, Lu Ting-Ren and Wu Hong-Ying, Avian Flu; Pathogenesis and Therapy, Anti-Infective Agents 2012; 10 (2) . https://dx.doi.org/10.2174/2211362611208020124
| DOI https://dx.doi.org/10.2174/2211362611208020124 |
Print ISSN 2211-3525 |
| Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Capillary Electrophoresis Interfaced with a Mass Spectrometer (CE-MS): Technical Considerations and Applicability for Biomarker Studies in Animals
Current Protein & Peptide Science An Overview of Published Papers and Important Developments in the Past Three Years
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inhibition of Product Template (PT) Domain of Aflatoxin Producing Polyketide Synthase Enzyme of Aspergillus parasiticus
Letters in Drug Design & Discovery Enhancement of Epidermal Basement Membrane Formation by Synthetic Inhibitors of Extracellular Matrix-degrading Enzymes
Current Tissue Engineering (Discontinued) Metabolic Therapy of Heart Failure
Current Pharmaceutical Design Molecularly Imprinted Sol-Gel Materials for Medical Applications
Current Topics in Medicinal Chemistry Diet and the Anti-inflammatory Effect of Heat Shock Proteins
Endocrine, Metabolic & Immune Disorders - Drug Targets New Insights into the Pathogenesis of and Long-Term Risks in Children with Henoch-Schonlein Purpura Nephritis
Current Pediatric Reviews Overview of the Role of Annexin 1 in the Innate and Adaptive Immune Response
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Intra-Renal Hemodynamic Changes After Habitual Physical Activity in Patients with Chronic Kidney Disease
Current Pharmaceutical Design Nutrition and Nutritional Management of Crohns Disease in Children and Adolescents
Current Nutrition & Food Science GPR18 and GPR55-related Ligands Serving as Antagonists or Agonists: Current Situation, Challenges and Perspectives
Medicinal Chemistry Signal Transduction of Steroidogenic Hormones to the Adrenal and Gonadal Mitochondria and the Possibilities for Combating Lipoid Congenital Adrenal Hyperplasia
Current Signal Transduction Therapy Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?
Current Drug Targets Crosstalk between the CX3CL1/CX3CR1 Axis and Inflammatory Signaling Pathways in Tissue Injury
Current Protein & Peptide Science Post-COVID-19 Gastro-Intestinal Disturbances
Reviews on Recent Clinical Trials Hair Growth: Focus on Herbal Therapeutic Agent
Current Drug Discovery Technologies Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches
Anti-Cancer Agents in Medicinal Chemistry Is there a Potential Immune Dysfunction with Anabolic Androgenic Steroid Use?: A Review
Mini-Reviews in Medicinal Chemistry The Identification of the SIRT1 Activator SRT2104 as a Clinical Candidate
Letters in Drug Design & Discovery





